के बारे में डॉ. रेड्डी की प्रयोगशालाओं की

• उद्योग Biotechnology & Drugs
• आईएसआईएन INE089A01031
• बीएसई कोड 500124
• एनएसई कोड DRREDDY

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

डॉ. रेड्डी की प्रयोगशालाओं की मैनेजमेंट

• Kallam Reddy Executive Chairman of the Board
• Gunupati Prasad Executive Co-Chairman, Managing Director
• Erez Israeli Chief Executive Officer
• Mannam Narasimham Chief Financial Officer
• Patrick Aghanian Chief Executive Officer, European Generics
• M. Ramana Chief Executive Officer, Branded Markets (India and Emerging Markets)
• Deepak Sapra Chief Executive Officer - API and Services
• Phanimitra B Chief Digital and Information Officer
• K. Singh Compliance Officer, Company Secretary, Head - CSR
• Sushrut Kulkarni Global Head - Integrated Product Development Organisation